News

uMotif delighted to announce Willie Muehlhausen, eCOA subject matter expert, as member of advisory board

uMotif building an advisory group of world-leading experts to make patient-centric clinical research a reality
Read more

Read our latest article in Applied Clinical Trials

Check out our latest article exploring the importance of human centred design for true patient centricity in pharmaceutical research, authored by our CEO Bruce Hellman and IDEO Portfolio Director Betsy Fields Smith.
Read more

We're Hiring!

We're further strengthening our sales and marketing team - putting the patient at the centre of clinical research. Come and join us!
Read more

An Unforgettable First SCDM Experience in Seattle

uMotif CEO, Bruce Hellman, shares his highlights from SCDM 2018
Read more

uMotif welcome Andrew McDonagh as Chief Technology Officer

uMotif investing in top software development talent to build the technology platform putting patients at the centre of clinical research.
Read more

uMotif attending SCDM 2018 Annual Conference in Seattle

uMotif team to join life science & data management colleagues to discuss the importance of patient-centric design in real world data capture
Read more

uMotif nominated for OBN award

We're a finalist in the 'Best implementation of digital technology for healthcare' category
Read more

Our employee interview series continues with a technology focus

Learn about how we manage our Infrastructure and ensure performance with Michal and Greg
Read more

uMotif secures £2.4 million funding - led by Albion Capital

We're delighted to secure this round of funding. It will enable us to bring on even more world class talent and remain at the forefront of patient-centric technology.
Read more

uMotif and OMRON Healthcare join forces to deliver patient-centred clinical research of the future

Creating a complete solution for cost-efficient, fast and high-quality clinical research by integrating high quality vitals, eCOA / ePRO and symptoms data
Read more

We're hiring!

We're growing across the company - building the team to put patients at the centre of clinical research. Come join us!
Read more

uMotif welcome Jonathan Stone as Vice President of Business Development (Americas and APAC)

uMotif investing in top business development talent to help the industry put the patient at the centre of clinical research.
Read more

Guardian Article: The app that could save lives by speeding up drug trials

uMotif profiled in major newspaper highlighting the importance of patient first trials and people owning their own data
Read more

Introducing our series of employee blogs and interviews with the uMotif team.

uWrite Volume 1: Quality with Michael Burke, QMS specialist
Read more

Knect 365 article: Enabling Bring Your Own Device Clinical Data Collection

uMotif CEO Bruce Hellman explores how patient-centric data capture can revolutionise clinical trials
Read more

uMotif collaborating with IQVIA and Emis Health for NIHR We've Got Your Back study

Unique approach to use an integrated platform to help GPs recruit more patients in clinical research
Read more

OurBrainBank publishes first feedback from patients

The glioblastoma initiative, supported by uMotif, is receiving fantastic feedback from patients and their caregivers as well as insights into what they expect from their care
Read more

Steve Powell joins uMotif Board of Directors

uMotif adds the accomplished software leader behind some of the most successful patient engagement and clinical trial management platforms to our leadership team.
Read more

uMotif featured in the Promise of HealthTech report

Report names uMotif as one of the 27 most promising HealthTech companies
Read more

uMotif partnering with Novartis and IQVIA on NHS Cancer Vanguard project

We’re delighted to be providing our data capture platform to support this work
Read more

5 Reasons to Join a Trade Mission

Rob Nichols, VP of Customer Experience, fresh from such a trip to Vienna, gives his view
Read more

Read our article published in the latest Journal of mHealth

Driving Real-World Research Through Patient-Centric Engagement
Read more

Our team grows with over 10 new hires since the start of 2018

We're building the team to deliver next generation patient data capture platform for clinical research
Read more

uMotif powered non-profit tackling brain cancer is now live

OurBrainBank is created by, with and for patients with Glioblastoma - one of the most aggressive, complex and deadly forms of cancer.
Read more

We’re recruiting!

We’re currently growing our engineering, sales and account delivery teams as we take our patient-centric approach to more clients and patients.
Read more

uMotif nominated by Journal of mHealth in the 'Global Digital Health 100'

We're delighted to have been nominated as one of the world's leading digital health companies by the Journal of mHealth
Read more

Deployment in colorectal cancer at Christie Cancer Vanguard proven successful

A poster presentation at the BOPA conference in the UK shows successful deployment of uMotif at the Christie hospital
Read more

uMotif platform proven to engage patients in studies

A paper published in JMIR demonstrates that uMotif is the most effective platform to engage patients in data capture for research
Read more

Patients, like holidaymakers, should be at the centre of their journey

Hotwire featured an article on patient centricity by our CEO, Bruce Hellman
Read more

Self-tracking proven to improve cancer survival rates

A peer-review published study has shown that patients who self-track their health have significantly better cancer outcomes and survival rates
Read more

uMotif powering new patient-centric movement in brain cancer

A new patient-powered movement - Our Brain Bank - aims to move brain cancer from terminal to treatable, powered by patients using uMotif technology
Read more

Amazon Web Services case study on uMotif

Our cloud based data capture technology has been featured as a case study by Amazon Web Services, our hosting provider
Read more

uMotif wins 'Professional's Choice' category at AXA PPP HealthTech & You Awards

We picked up another award at the AXA PPP HealthTech & You Awards, scooping the 'Professional's Choice' category for engaging patients in large-scale research projects
Read more

New partnership with SQN for patient-centric data capture for clinical trials

Our new partnership will provide clinical trial sponsors with patient-centric technology for trials of all phases, including Real-World Evidence.
Read more

uMotif featured on BBC World Service 'World Hacks' programme

The BBC World Service's programme 'World Hacks' covered the growing interest in patients donating their health data for research, focusing on the uMotif platform
Read more

The dataset from 100 For Parkinson's exceeds 2.2 million data points

The final patients have completed their 100 Days of tracking for 100 For Parkinson's, so we now have the final dataset containing over 2.2 million datapoints. The latest analyses are ...
Read more

uMotif signs new partnership with AstraZeneca to enhance patient data capture

uMotif has signed a partnership agreement with AstraZeneca, a top-10 global pharmaceutical company
Read more

uMotif and QuintilesIMS in partnership with the NHS Cancer Vanguard and Merck launch a unique investigation into the experience of Colorectal Cancer Patients

uMotif in partnership with QuintilesIMS was chosen from dozens of responses to the ‘Pharma Challenge’, an invitation issued by the NHS Cancer Vanguard to the pharmaceutical and life sciences industry to help the NHS make better use of medicines and minimise waste.
Read more

Gold-standard RCT shows that uMotif effectively engages patients to track and manage their condition over time - resulting in significant clinical impact

A new study in Parkinson’s proves the value and clinical impact of patients using their own devices to capture and monitor symptoms and treatments.
Read more

Capturing trial data to help understand the good days, as well as the bad: Sam's Story

Using the uMotif app during the Smart PD trial, Sam was able to get a better understanding of her Parkinson's
Read more

uMotif announce partnership with Global Kinetics

​Global Kinetics Corporation and uMotif have announced a new partnership to offer a comprehensive, validated and simple to use data capture platform to advance the treatment and understanding of Parkinson's disease.
Read more

Putting patients at the centre of research - Mick's experience of using uMotif

Watch the latest video, where one of the participants from our observational study describes his experience using the uMotif app
Read more

Cloudy with a Chance of Pain is Front Page News!

Our collaboration with the University of Manchester is featured on the FRONT PAGE of the Daily Express today - describing the preliminary findings that the weather may.....
Read more

100 For Parkinson’s enters its last two weeks of recruitment

Our ground-breaking study in partnership with The Cure Parkinson’s Trust, Parkinson’s UK and the European Parkinson’s Disease Association is entering the last two weeks of recruitment. There’s still time for people with Parkinson’s and healthy volunteers to join over 4000 others and track their health for 100 days using their own smartphone or tablet.
Read more

Digital Innovators Power List

umotif has been named as one of the South East's most visionary digital companies in the inaugural 'Digital Innovators Power List' launched today by international law firm Bird & Bird LLP and London-based news brand, City A.M.
Read more

uMotif and Oxford University Innovation collaborate on world’s largest health tracking study to improve the lives of those with Parkinson’s

 One person in every 500 has Parkinson’s disease, with more than 127,000 people in the UK and around 10 million people globally diagnosed with the condition.  A unique global health project – 100 for Parkinson’s - has engaged thousands of people across the world to track their health, using smartphone technology, to provide valuable new insights on the impact of Parkinson’s on their daily lives.   With over 4,000 participants and millions of data points captured, the study is now the world’s largest of its type in Parkinson’s, capturing more high quality health data from more patients over a longer period of time.
Read more

It's World Parkinson's Congress and we've more data to share...

World Parkinson's Congress is ending today in Portland, so we've published some more data from 100 For Parkinson's on Mood, Sleep and Stress levels of those with and without Parkinson's...
Read more

Cloudy with a Chance of Pain study

​Preliminary results, national media coverage and another 2,500 participants: It's been another couple of eventful weeks for the ground-breaking Cloudy with a Chance of Pain study
Read more

Partnership with Picker Institute, using patient experience to reduce readmissions

We're delighted to be working in partnership with the Picker Institute – the leading charity improving healthcare through measurement of experience.
Read more

Data from global 100 for Parkinson’s study

​We launched our global 100 for Parkinson's study at the start of 2016, and have had an incredible response.
Read more

Guardian article: People powered health

u​Motif CEO Bruce Hellman wrote an article in the Guardian on the future of technology in healthcare.
Read more

IDEO Startup In Residence

A year ago the uMotif team started working with the IDEO London team, as part of their incredible Startup In Residence Programme.
Read more